|
NYNRIN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13170003870999E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.79409999984715E-07 |
| Normal-vs-Stage2 |
5.26190202521093E-11 |
| Normal-vs-Stage3 |
4.5809023241361E-11 |
| Normal-vs-Stage4 |
3.26360050095786E-11 |
| Stage1-vs-Stage2 |
2.236400E-04 |
| Stage1-vs-Stage3 |
4.39520000000693E-05 |
| Stage1-vs-Stage4 |
1.406150E-04 |
| Stage2-vs-Stage3 |
4.860200E-01 |
| Stage2-vs-Stage4 |
9.334600E-01 |
| Stage3-vs-Stage4 |
4.395800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.1698000346172E-09 |
| Normal-vs-AfricanAmerican |
1.639160E-04 |
| Normal-vs-Asian |
1.403790E-01 |
| Caucasian-vs-AfricanAmerican |
2.848200E-01 |
| Caucasian-vs-Asian |
2.267400E-01 |
| AfricanAmerican-vs-Asian |
6.832600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59369994978675E-09 |
| Normal-vs-Female |
1.44909999555409E-08 |
| Male-vs-Female |
4.801800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.276000E-03 |
| Normal-vs-Age(41-60Yrs) |
9.37249999832801E-09 |
| Normal-vs-Age(61-80Yrs) |
2.0763000208035E-09 |
| Normal-vs-Age(81-100Yrs) |
7.24610371705126E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.442000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.553220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.195710E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.919000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.622400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.093620E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.373400E-01 |
| Normal-vs-Grade 2 |
6.32030000002892E-07 |
| Normal-vs-Grade 3 |
1.63199453950824E-11 |
| Normal-vs-Grade 4 |
6.28620044906825E-10 |
| Grade 1-vs-Grade 2 |
3.107900E-02 |
| Grade 1-vs-Grade 3 |
9.500400E-03 |
| Grade 1-vs-Grade 4 |
5.038700E-04 |
| Grade 2-vs-Grade 3 |
1.98202999999175E-05 |
| Grade 2-vs-Grade 4 |
6.863300E-03 |
| Grade 3-vs-Grade 4 |
8.544400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.63450003426635E-09 |
| Normal-vs-ccB subtype |
3.6131999947564E-08 |
| ccA subtype-vs-ccB subtype |
6.737200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.86880005598789E-10 |
| Normal-vs-N1 |
3.6087000054863E-08 |
| N0-vs-N1 |
2.506600E-01 |
|
|
